Showing results (331-340 of 349) with videos related to
Sort By:
Pageof 35
British Journal of Cancer|August 17, 2000
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapseW K Yung, R E Albright, J Olson, et al.Annals of Surgery|April 1, 2024
Evaluation of Short and Long-term Outcomes After Resection in Patients With Locally Advanced Versus (Borderline) Resectable Pancreatic CancerLilly J H Brada, Thijs J Schouten, Lois A Daamen, et al.Journal of Medical Ethics|September 19, 2013
Position statement on ethics, equipoise and research on charged particle radiation therapyMark Sheehan, Claire Timlin, Ken Peach, et al.Cancers|July 25, 2019
Locally Advanced Pancreatic Cancer: Work-Up, Staging, and Local Intervention StrategiesEran van Veldhuisen, Claudia van den Oord, Lilly J Brada, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2015
Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosomeF Favero, N McGranahan, M Salm, et al.Nature|December 3, 2010
Integrative genomics identifies LMO1 as a neuroblastoma oncogeneKai Wang, Sharon J Diskin, Haitao Zhang, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2018
Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancerB Basu, M G Krebs, R Sundar, et al.Journal of Surgical Oncology|June 11, 2021
Predicting overall survival and resection in patients with locally advanced pancreatic cancer treated with FOLFIRINOX: Development and internal validation of two nomogramsLilly J H Brada, Marieke S Walma, Lois A Daamen, et al.Annals of Surgery|August 11, 2022
Early Recurrence After Resection of Locally Advanced Pancreatic Cancer Following Induction Therapy: An International Multicenter StudyLeonard W F Seelen, Anne Floortje van Oosten, Lilly J H Brada, et al.Annals of Surgery|August 2, 2021
Survival Benefit Associated With Resection of Locally Advanced Pancreatic Cancer After Upfront FOLFIRINOX Versus FOLFIRINOX Only: Multicenter Propensity Score-matched AnalysisLilly J H Brada, Lois A Daamen, Lisa G Magermans, et al.Pageof 35